Public Employees Retirement Association of Colorado Trims Holdings in CVS Health Co. (NYSE:CVS)

Public Employees Retirement Association of Colorado lessened its stake in CVS Health Co. (NYSE:CVS - Free Report) by 2.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 169,617 shares of the pharmacy operator's stock after selling 4,410 shares during the quarter. Public Employees Retirement Association of Colorado's holdings in CVS Health were worth $7,614,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. Morse Asset Management Inc acquired a new stake in CVS Health during the third quarter worth approximately $409,000. Westside Investment Management Inc. increased its position in CVS Health by 4.6% during the 3rd quarter. Westside Investment Management Inc. now owns 64,517 shares of the pharmacy operator's stock worth $4,041,000 after buying an additional 2,856 shares during the period. World Investment Advisors LLC boosted its position in shares of CVS Health by 280.7% in the third quarter. World Investment Advisors LLC now owns 27,543 shares of the pharmacy operator's stock valued at $1,732,000 after acquiring an additional 20,308 shares during the period. Wilmington Savings Fund Society FSB acquired a new stake in CVS Health in the 3rd quarter worth about $2,071,000. Finally, Tidal Investments LLC boosted its stake in shares of CVS Health by 52.2% in the third quarter. Tidal Investments LLC now owns 112,010 shares of the pharmacy operator's stock valued at $7,043,000 after buying an additional 38,408 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Down 2.8 %

CVS traded down $1.96 during mid-day trading on Friday, reaching $67.49. 14,303,584 shares of the stock were exchanged, compared to its average volume of 11,558,641. The company has a 50 day moving average price of $66.64 and a two-hundred day moving average price of $58.87. The stock has a market capitalization of $85.09 billion, a PE ratio of 18.44, a price-to-earnings-growth ratio of 0.98 and a beta of 0.57. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The business had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. During the same quarter last year, the company posted $1.31 earnings per share. The firm's quarterly revenue was up 7.0% compared to the same quarter last year. As a group, research analysts anticipate that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.94%. CVS Health's payout ratio is 72.68%.

Insiders Place Their Bets

In other CVS Health news, Director Michael F. Mahoney acquired 30,000 shares of the stock in a transaction dated Tuesday, February 18th. The stock was purchased at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the acquisition, the director now owns 39,356 shares in the company, valued at $2,625,045.20. The trade was a 320.65 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP James David Clark sold 7,513 shares of CVS Health stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the transaction, the senior vice president now owns 8,394 shares in the company, valued at approximately $556,941.90. The trade was a 47.23 % decrease in their position. The disclosure for this sale can be found here. 1.22% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

CVS has been the subject of a number of recent analyst reports. StockNews.com raised shares of CVS Health from a "sell" rating to a "hold" rating in a report on Thursday, February 13th. JPMorgan Chase & Co. boosted their target price on CVS Health from $80.00 to $81.00 and gave the stock an "overweight" rating in a research note on Tuesday, February 18th. Wolfe Research lifted their price target on shares of CVS Health from 67.00 to 70.00 and gave the company an "overweight" rating in a report on Tuesday, February 11th. Morgan Stanley reissued an "overweight" rating on shares of CVS Health in a research note on Tuesday, April 15th. Finally, Barclays upped their price target on shares of CVS Health from $73.00 to $82.00 and gave the stock an "overweight" rating in a report on Friday. Four investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $73.00.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.